The interaction of VDAC with other cytosolic proteins, i.e., pro- or anti-apoptotic, for cell survival or death provides a potential therapeutic target to mitigate cell injury, as in IR injury and neurodegenerative diseases, or instigate cell death, as in neoplastic diseases (discussed below). Here, VDAC1 is linked to neurodegenerative disease.